Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of N-(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT2A Receptor Agonist

Anders A. Jensen(University of Copenhagen), Jesper L. Kristensen(University of Copenhagen), Sebastian Leth‐Petersen(University of Copenhagen), Jan Kehler(University of North Carolina at Chapel Hill), Christoffer Bundgaard(University of North Carolina at Chapel Hill), Hans Bräuner‐Osborne(University of Copenhagen), Gudrun Liebscher(Innsbruck Medical University), Terry Kenakin(University of North Carolina at Chapel Hill), John D. McCorvy(Medical College of Wisconsin)
Journal of Pharmacology and Experimental Therapeutics
March 31, 2017
Cited by 62


Related Papers